These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1017467)

  • 1. Radiopaque contrast media. XLII-Metabolism of iopronic acid in human.
    Pitrè D; Felder E
    Farmaco Prat; 1976 Oct; 31(10):540-6. PubMed ID: 1017467
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiopaque contrast media. XL- Isolation and identification of the metabolites of iopronic acid in the urine and bile of the dog.
    Pitrè
    Farmaco Prat; 1976 Oct; 31(10):516-28. PubMed ID: 1017465
    [No Abstract]   [Full Text] [Related]  

  • 3. Radiopaque contrast media. XLI-Isolation and identification of the metabolites of iopronic acid in the rat.
    Pitrè D; Fumagalli L
    Farmaco Prat; 1976 Oct; 31(10):529-39. PubMed ID: 1017466
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biotransformation of iomeglamic acid (Falignost)].
    Bornschein I; Borchert HH; Pfeifer S
    Pharmazie; 1974; 29(10-11):730-1. PubMed ID: 4438422
    [No Abstract]   [Full Text] [Related]  

  • 5. Radiopaque contrast media. XXXIX - Metabolism of iopronic acid by rat liver microsomes: characterization and identification of the metabolites.
    Pitrè D; Facino RM
    Farmaco Sci; 1976 Oct; 31(10):755-62. PubMed ID: 1010025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro binding and metabolism of iopronic acid by rat liver microsomes.
    Raffaeli E; Facino RM; Salmona M; Pitré D
    Pharmacol Res Commun; 1977 Oct; 9(9):833-46. PubMed ID: 609577
    [No Abstract]   [Full Text] [Related]  

  • 7. [Radiopaque contrast media. XXXVI - Iopronic acid: proposed analytical monograph].
    Felder E; Zingales MF; Tiepolo U
    Farmaco Prat; 1976 Aug; 31(8):383-95. PubMed ID: 955052
    [No Abstract]   [Full Text] [Related]  

  • 8. Radiopaque contrast media. XXXVII-Iopronic acid, a new contrast medium for oral cholecystography: pharmacologic investigation.
    Tirone P; Rosati G
    Farmaco Prat; 1976 Aug; 31(8):397-412. PubMed ID: 955053
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biotransformation of iodoxanic acid in humans].
    Pitrè D; Fumagalli L
    Radiol Med; 1970 Sep; 56(9):836-43. PubMed ID: 5210612
    [No Abstract]   [Full Text] [Related]  

  • 10. Biliary excretion of three cholecystographic contrast agents in dogs: iocetamic acid, iopronic acid and iosumetic acid.
    Barnhart JL; Berk RN; Czuleger PC
    Invest Radiol; 1979; 14(1):79-87. PubMed ID: 158000
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiopague contrast media. Part 30. New heterocyclic derivatives of triiodophenoxy alkanoic acids.
    Fumagalli L; Felder E; Pitré D
    Pharmazie; 1975 Feb; 30(2):78-9. PubMed ID: 1144505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiopaque contrast media. XXIX - Metabolism studies with iodoxamic acid.
    Pitrè D; Felder E
    Farmaco Sci; 1974 Oct; 29(10):793-801. PubMed ID: 4435214
    [No Abstract]   [Full Text] [Related]  

  • 13. Radiopaque contrast media. XXXVIII - Iopronic acid, a new contrast medium for oral cholecystography: toxicologic investigation.
    Tirone P; Rosati G
    Farmaco Prat; 1976 Sep; 31(9):437-46. PubMed ID: 1010018
    [No Abstract]   [Full Text] [Related]  

  • 14. Radiological contrast mediums. XIX. Urinary metabolites of iodoxanic acid in man.
    Pitrè D; Fumagalli L; Fonberg-Broczek M
    Farmaco Sci; 1971 Oct; 26(10):882-90. PubMed ID: 5157787
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results and conclusions from metabolic studies of I 131 -falignost].
    Barke R; Hieckel HG
    Radiol Diagn (Berl); 1972; 13(6):805-15. PubMed ID: 4657544
    [No Abstract]   [Full Text] [Related]  

  • 16. The fate of an experimental MAO inhibitor, N-cyclopropyl-2-chlorophenoxyethylamine (Lilly 51641) in the rat and in man.
    Sullivan HR; Billings RE; Fasola AF; McMahon RE
    Xenobiotica; 1971 Nov; 1(6):621-30. PubMed ID: 5173025
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biotransformation of iomeglamic acid (Falignost)].
    Bornschein I; Schäffner J; Pfeifer S
    Pharmazie; 1975 Mar; 30(3):196. PubMed ID: 1153481
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biotransformation of iomeglamic acid (Falignost)].
    Pfeifer S; Schäffner J; Bornschein I
    Pharmazie; 1972 Sep; 27(9):616-7. PubMed ID: 5086367
    [No Abstract]   [Full Text] [Related]  

  • 19. The metabolism of tamoxifen (I.C.I. 46,474). I. In laboratory animals.
    Fromson JM; Pearson S; Bramah S
    Xenobiotica; 1973 Nov; 3(11):693-709. PubMed ID: 4361333
    [No Abstract]   [Full Text] [Related]  

  • 20. Radiopaque contrast media. XXXIV - Derivatives of omega-(3-amino-2,4,6-triiodophenoxy)alkoxyalkanoic acids.
    Felder E; Pitrè D; Fumagalli L; Lorenzotti E
    Farmaco Sci; 1976 May; 31(5):349-63. PubMed ID: 1269739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.